Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Pharmaceutics|May 27, 2026
Anti-Inflammatory Properties of Curcumin as Add-On Therapy in Patients with MS-Prospective, Comparative, Randomized, Pilot StudyAnna Kukushkina, Vladimir Rogovskii, Olga Zhilenkova, et al.
International Journal of Molecular Sciences|January 21, 2022
The Dual Role of the β<sub>2</sub>-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple SclerosisMikhail Melnikov, Vladimir Rogovskii, Anastasiya Sviridova, et al.
Journal of Neuroimmunology|May 17, 2021
The role of 5-HT<sub>2B</sub>-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosisAnastasiya Sviridova, Vladimir Rogovskii, Vladimir Kudrin, et al.
Frontiers in Neurology|August 8, 2022
Serotonergic drug repurposing in multiple sclerosis: A new possibility for disease-modifying therapyMikhail Melnikov, Dmitriy Kasatkin, Anna Lopatina, et al.
Current Neuropharmacology|August 25, 2021
The Role of D<sub>2</sub>-like Dopaminergic Receptor in Dopamine-mediated Modulation of Th17-cells in Multiple SclerosisMikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, et al.
Brain Sciences|September 19, 2020
Hyperhomocysteinemia and Endothelial Dysfunction in Multiple SclerosisEkaterina Dubchenko, Alexander Ivanov, Natalia Spirina, et al.
Asian Journal of Psychiatry|July 19, 2025
The role of neuroinflammation in schizophrenia: Focus on Th17 cells functionsMikhail Melnikov, Anna Lopatina, Anastasiya Sviridova, et al.
Multiple Sclerosis and Related Disorders|March 23, 2021
Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapyMikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, et al.
Plos One|October 30, 2020
The influence of glatiramer acetate on Th17-immune response in multiple sclerosisMikhail Melnikov, Svetlana Sharanova, Anastasiya Sviridova, et al.
Pageof 3